Prevalance of Cesarean Section Niche in Patients With Abnormal Uterine Bleeding
Launched by MAHMOUD RAMADAN HAFEZ · Sep 23, 2021
Trial Information
Current as of July 24, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age between 20-40 years old. Non pregnant women. Previous cesarean section (one or more). Presence of abnormal uterine bleeding
- Exclusion Criteria:
- • Virgins Pregnant women. Patients with vaginal delivery. Patients with uterine bleeding with known cause.
About Mahmoud Ramadan Hafez
Mahmoud Ramadan Hafez is a dedicated clinical trial sponsor with a commitment to advancing medical research and innovation. With a strong background in clinical study management, he oversees the design, implementation, and monitoring of trials aimed at evaluating new therapeutic interventions. His strategic approach emphasizes ethical considerations, regulatory compliance, and patient safety, ensuring that all research initiatives contribute valuable insights to the medical community. Through collaborative partnerships with healthcare professionals and research institutions, Mahmoud strives to enhance treatment outcomes and foster a culture of scientific excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sohag, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials